Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Other financing activities (2022 - 2025)

Rxo (RXO) has disclosed Other financing activities for 5 consecutive years, with $1.0 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Other financing activities rose 200.0% year-over-year to $1.0 million, compared with a TTM value of -$10.0 million through Dec 2025, down 133.33%, and an annual FY2025 reading of -$10.0 million, down 133.33% over the prior year.
  • Other financing activities was $1.0 million for Q2 2025 at Rxo, up from -$11.0 million in the prior quarter.
  • Across five years, Other financing activities topped out at $21.0 million in Q4 2024 and bottomed at -$11.0 million in Q1 2025.
  • Average Other financing activities over 5 years is $1.9 million, with a median of $0.0 recorded in 2021.
  • The sharpest move saw Other financing activities changed 0.0% in 2022, then soared 900.0% in 2024.
  • Year by year, Other financing activities stood at -$1.0 million in 2021, then changed by 0.0% to -$1.0 million in 2022, then skyrocketed by 200.0% to $1.0 million in 2023, then skyrocketed by 2000.0% to $21.0 million in 2024, then crashed by 95.24% to $1.0 million in 2025.
  • Business Quant data shows Other financing activities for RXO at $1.0 million in Q2 2025, -$11.0 million in Q1 2025, and $21.0 million in Q4 2024.